Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'.

Br J Cancer · 2009 · PMC2736811 · PMID 19623175

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was also a higher incidence of concurrent mutation of FLT3/ITD , FLT3/TKD , AML1/RUNX1 or MLL/PTD in CEBPA single-mut patients than in CEBPA double-mut patients (20.8 vs 10.6%, 12.5 vs 4.3%, 8.3 vs 2.1% and 4.2 vs 0%, respectively), but the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.